Geopolitics Alpha

8-K - SELLAS Life Sciences Group, Inc. (0001390478) (Filer)

Published . Updated .

Key takeaways

  • 8-K - SELLAS Life Sciences Group filed an 8-K with the SEC on Nov 17 (a notice of a material company event).
  • Exposed: SLS
  • Market reaction: price tracking starts with the next trading session.

Market Call

Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.

Get these market calls by email

The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.

Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.

GEOPOLITICS ALPHA8-K - SELLAS Life Sciences Group,Inc. (0001390478) (Filer)SLSGEOPOLITICS ALPHA

8-K - SELLAS Life Sciences Group filed an 8-K with the SEC on Nov 17 (a notice of a material company event).

Directly affected

  • SLS SELLAS Life Sciences Group-30.3% 30d

    Named in this report.

Indirectly affected

  • XLV Health Care Select Sector SPDR

    Health Care Select Sector SPDR holds the health sector that SELLAS Life Sciences Group belongs to, so it often moves with news about it.

  • LLY Eli Lilly and+25.1% 30d

    Eli Lilly and is a peer of SELLAS Life Sciences Group in pharmaceutical preparations; rivals often move on the same news.

  • JNJ Johnson & Johnson+12.1% 30d

    Johnson & Johnson is a peer of SELLAS Life Sciences Group in pharmaceutical preparations; rivals often move on the same news.

  • ABBV AbbVie+12.0% 30d

    AbbVie is a peer of SELLAS Life Sciences Group in pharmaceutical preparations; rivals often move on the same news.

  • MRK Merck+3.5% 30d

    Merck is a peer of SELLAS Life Sciences Group in pharmaceutical preparations; rivals often move on the same news.

  • ABT Abbott Laboratories+10.0% 30d

    Abbott Laboratories is a peer of SELLAS Life Sciences Group in pharmaceutical preparations; rivals often move on the same news.

Price reaction, T-5 to T+3

TickerT-5T-3T-1T0T+1T+2T+3
SLS+12.05%+7.43%baseafter closeafter closeafter closeafter close
XLV+0.52%-0.04%baseafter closeafter closeafter closeafter close
LLY-0.12%-0.28%baseafter closeafter closeafter closeafter close
JNJ-0.65%+0.33%baseafter closeafter closeafter closeafter close
ABBV-0.23%-0.02%baseafter closeafter closeafter closeafter close
MRK+2.39%+1.67%baseafter closeafter closeafter closeafter close
ABT+2.73%-0.23%baseafter closeafter closeafter closeafter close

Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.

Filed: 2026-11-17 AccNo: 0001104659-26-128825 Size: 227 KB Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

Source: sec-edgar

SELLAS Life Sciences Group (SLS) since “8-K - SELLAS Life Sciences Group, Inc. (0001390478) (Filer),” compared with the market

CompanyWhenMoveStatus
ABBVthree days earlier-0.02%final price
ABBVfive days earlier-0.23%final price
ABTthree days earlier-0.23%final price
ABTfive days earlier+2.73%final price
JNJthree days earlier+0.33%final price
JNJfive days earlier-0.65%final price
LLYthree days earlier-0.28%final price
LLYfive days earlier-0.12%final price
MRKthree days earlier+1.67%final price
MRKfive days earlier+2.39%final price
SELLAS Life Sciences Group (SLS)three days earlier+7.43%final price
SELLAS Life Sciences Group (SLS)five days earlier+12.05%final price
XLVthree days earlier-0.04%final price
XLVfive days earlier+0.52%final price

Congressional trades in the stocks in this story

Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).

Who is named in “8-K - SELLAS Life Sciences Group, Inc. (0001390478) (Filer)”

Companies carried with this story

  • SLS SELLAS Life Sciences Group

    In “8-K - SELLAS Life Sciences Group, Inc. (0001390478) (Filer),” SELLAS Life Sciences Group (SLS) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> SLS

How “8-K - SELLAS Life Sciences Group, Inc. (0001390478) (Filer)” reaches SELLAS Life Sciences Group (SLS)

On 17 Nov 2026, “8-K - SELLAS Life Sciences Group, Inc. (0001390478) (Filer)” is the story that connects SELLAS Life Sciences Group (SLS) to this story.

The link for SELLAS Life Sciences Group (SLS) is this: SEC 8-K filing -> direct issuer disclosure -> SLS

Dates in the story, and the SELLAS Life Sciences Group (SLS) price range

SLS traded between 8.00 and 12.69 across 18 sessions. The latest close on file is 8.02.

How solid “8-K - SELLAS Life Sciences Group, Inc. (0001390478) (Filer)” looks

14 out of 100

“8-K - SELLAS Life Sciences Group, Inc. (0001390478) (Filer)” scores 14 out of 100. The score uses 1 source, and 1 linked company.